Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut–liver axis

Fig. 2

a, b Liver indices and IR indices of the rats in each group compared by one-way analysis of variance (ANOVA) followed by the least significant difference (LSD) multiple comparison test. ##P < 0.01 compared with Group N, **P < 0.01 compared with Group M. c, d ALT and AST levels in each group compared via the Kruskal–Wallis H test. *P < 0.05 compared with Group M, **P < 0.01 compared with Group M

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X